| First Author | Vanderhaeghen T | Year | 2022 |
| Journal | EMBO Rep | Volume | 23 |
| Issue | 1 | Pages | e53083 |
| PubMed ID | 34699114 | Mgi Jnum | J:317573 |
| Mgi Id | MGI:6856534 | Doi | 10.15252/embr.202153083 |
| Citation | Vanderhaeghen T, et al. (2022) Reprogramming of glucocorticoid receptor function by hypoxia. EMBO Rep 23(1):e53083 |
| abstractText | Here, we investigate the impact of hypoxia on the hepatic response of glucocorticoid receptor (GR) to dexamethasone (DEX) in mice via RNA-sequencing. Hypoxia causes three types of reprogramming of GR: (i) much weaker induction of classical GR-responsive genes by DEX in hypoxia, (ii) a number of genes is induced by DEX specifically in hypoxia, and (iii) hypoxia induces a group of genes via activation of the hypothalamic-pituitary-adrenal (HPA) axis. Transcriptional profiles are reflected by changed GR DNA-binding as measured by ChIP sequencing. The HPA axis is induced by hypothalamic HIF1alpha and HIF2alpha activation and leads to GR-dependent lipolysis and ketogenesis. Acute inflammation, induced by lipopolysaccharide, is prevented by DEX in normoxia but not during hypoxia, and this is attributed to HPA axis activation by hypoxia. We unfold new physiological pathways that have consequences for patients suffering from GC resistance. |
